IP Library Granted Patent US 11,293,021
Granted Patent B1
US 11,293,021 · App. 17/538,922 · Granted Apr 5, 2022

Automated cell processing methods, modules, instruments, and systems

Inventors: Jorge Bernate (Boulder, CO); Kevin Ness (Boulder, CO); Phillip Belgrader (Pleasanton, CA); Don Masquelier (Boulder, CO); Ryan Gill (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/1082C12M23/44C12M33/14C12M35/00C12M37/04C12M41/36C12M41/48C12M43/00C12N9/22C12N15/11C40B40/02C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,293,021
App. No.
17/538,922
Granted
Apr 5, 2022
Kind
B1
Abstract

In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.

Claims (47)

1. An automated stand-alone multi-module cell editing instrument comprising:

a housing configured to house all or some of the modules;

a receptacle configured to receive mammalian cells;

one or more receptacles configured to receive expression vectors, wherein the expression vectors introduce a desired DNA change to the target region and remove a proto-spacer motif (PAM) region from the target region;

a growth module for growing the mammalian cells for transformation;

a transformation module configured to introduce the expression vectors into the mammalian cells;

a nuclease-directed editing module configured to allow the introduced expression vectors to edit nucleic acids in the mammalian cells;

a magnetic separation module configured to separate edited mammalian cells from unedited mammalian cells;

a processor configured to operate the automated multi-module cell editing instrument based on user input and/or selection of a pre-programmed script; and

an automated liquid handling system to move liquids from the cell receptacle to the growth module; from the growth module to the transformation module; from the one or more receptacles configured to receive expression vectors to the transformation module; from the transformation module to the nuclease-directed editing module; and from the nuclease-directed editing module to the magnetic separation module without user intervention.

2. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the automated liquid handling system comprises a sipper or pipettor.

3. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the nuclease-directed editing module is also a recovery module.

4. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the automated stand-alone multi-module cell editing instrument further comprises a recovery module separate from the nuclease-directed editing module.

5. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module is separate from the transformation module.

6. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the transformation module performs a process selected from electroporation, lipofection, optoporation, injection, microprecipitation, magnetofection, microinjection, particle bombardment, sonoporation, laser-induced poration, bead transfection, calcium phosphate and calcium chloride co-precipitation, and DEAE-dextran-mediated transfection.

7. The automated stand-alone multi-module cell editing instrument of claim 6 , wherein the transformation module performs electroporation.

8. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the transformation module is combined with the nuclease-directed editing module.

9. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the transformation module is separate from the nuclease-directed editing module.

10. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module is combined with the transformation module.

11. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module is separate from the transformation module.

12. The automated stand-alone multi-module cell editing instrument of claim 1 , wherein the growth module, transformation module and nuclease-directed editing module are combined.

13. An automated stand-alone multi-module cell editing instrument comprising:

a housing configured to house all or some of the modules;

one or more receptacles configured to receive expression vectors, wherein the expression vectors introduce a desired DNA change to the target region and remove a proto-spacer motif (PAM) region from the target region;

a growth module for growing mammalian cells for transformation;

a transformation module configured to introduce the expression vectors into the mammalian cells;

a nuclease-directed editing module configured to allow the introduced expression vectors to edit nucleic acids in the mammalian cells;

a magnetic separation module configured to separate edited mammalian cells from unedited mammalian cells;

a processor configured to operate the automated multi-module cell editing instrument based on user input and/or selection of a pre-programmed script; and

an automated liquid handling system to move liquids from the growth module to the transformation module; from the one or more receptacles configured to receive expression vectors to the transformation module; from the transformation module to the nuclease-directed editing module; and from the nuclease-directed editing module to the magnetic separation module without user intervention.

14. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the nuclease-directed editing module is also a recovery module.

15. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the automated stand-alone multi-module cell editing instrument further comprises a recovery module separate from the nuclease-directed editing module.

16. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the transformation module performs a process selected from electroporation, lipofection, optoporation, injection, microprecipitation, magnetofection, microinjection, particle bombardment, sonoporation, laser-induced poration bead transfection, calcium phosphate and calcium chloride co-precipitation, and DEAE-dextran-mediated transfection.

17. The automated stand-alone multi-module cell editing instrument of claim 16 , wherein the transformation module performs bead transfection.

18. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the transformation module is combined with the nuclease-directed editing module.

19. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the transformation module is separate from the nuclease-directed editing module.

20. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the growth module is combined with the transformation module.

21. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the growth module is separate from the transformation module.

22. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the growth module, transformation module and nuclease-directed editing module are combined.

23. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the expression vectors are viral vectors.

24. The automated stand-alone multi-module cell editing instrument of claim 23 , wherein the viral vector is selected from a retrovirus vector, replication defective retrovirus vector, adenovirus vector, replication defective adenovirus vector, and adeno-associated virus vector and a lentivirus vector.

25. The automated stand-alone multi-module cell editing instrument of claim 24 , wherein the viral vector is an adenovirus vector.

26. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the mammalian cells are human cells.

27. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein a nuclease is delivered to the mammalian cells as a protein.

28. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein a nuclease is delivered to the mammalian cells as an expression sequence for a protein.

29. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the nuclease is a MAD7 nuclease.

30. The automated stand-alone multi-module cell editing instrument of claim 13 , wherein the nuclease is a Cas9 nuclease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2021
From: BERNATE, JORGE; NESS, KEVIN; BELGRADER, PHILLIP; MASQUELIER, DON; GILL, RYAN
To: INSCRIPTA, INC.
Reel/Frame 058248/0314 →
Continuity (26)
Continuation 17336244 · Jun 1, 2021
Continuation 17200443 · Mar 12, 2021
Continuation 17131582 · Dec 22, 2020
Continuation 16988694 · Aug 9, 2020
Continuation 16837985 · Apr 1, 2020
Continuation 16822249 · Mar 18, 2020
Continuation 16750369 · Jan 23, 2020
Continuation 16680643 · Nov 12, 2019
Continuation 16666964 · Oct 29, 2019
Continuation 16571091 · Sep 14, 2019
Continuation 16423289 · May 28, 2019
Continuation 16269655 · Feb 7, 2019
Continuation 16024816 · Jun 30, 2018
Provisional Application 62527339 · Jun 30, 2017
Provisional Application 62551069 · Aug 28, 2017
Provisional Application 62566374 · Sep 30, 2017
Provisional Application 62566375 · Sep 30, 2017
Provisional Application 62566688 · Oct 2, 2017
Provisional Application 62567697 · Oct 3, 2017
Provisional Application 62620370 · Jan 22, 2018
Provisional Application 62649731 · Mar 29, 2018
Provisional Application 62671385 · May 14, 2018
Provisional Application 62648130 · Mar 26, 2018
Provisional Application 62657651 · Apr 13, 2018
Provisional Application 62657654 · Apr 13, 2018
Provisional Application 62689068 · Jun 23, 2016
Cited By (1)
US 1,094,768